Jacob Pe’er
- Ophthalmology top 0.1%
- Ocular Oncology and Treatments 80
- Glaucoma and retinal disorders 17
- Ocular Infections and Treatments 10
- Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research 11
- Cancer Research top 1%
- Oncology top 1%
- Cutaneous Melanoma Detection and Management 16
-
- Corneal Surgery and Treatments 20
-
- Ocular Surface and Contact Lens 16
-
- Retinal Development and Disorders 13
- Co-authors
- Robert FolbergAhuva ItinEli KeshetItzhak HemoAndrew J. ManiotisJonathan StoneTamir AlonJeffrey M. Trent
- Journals
- Investigative Ophthalmology & Visual Science (24 papers)Ophthalmology (15 papers)American Journal of Ophthalmology (11 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Jacob Pe’er
148 papers receiving 7.5k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Ophthalmology 3.3k
- Immunology and Allergy 733
- Cancer Research 1.2k
- Oncology 1.8k
- Radiology, Nuclear Medicine and Imaging 1.5k
Countries citing papers authored by Jacob Pe’er
This map shows the geographic impact of Jacob Pe’er's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Pe’er with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Pe’er more than expected).
Fields of papers citing papers by Jacob Pe’er
This network shows the impact of papers produced by Jacob Pe’er. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Pe’er. The network helps show where Jacob Pe’er may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jacob Pe’er, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | A novel type of corneal epitheliopathy from a new class of antibody-drug conjugate anti-cancer treatments | 2020 | 2 |
| 4 | Topical interferon alpha 2a for ocular surface tumors | 2020 | 2 |
| 5 | The Use of Intravitreal Methotrexate for Treating Vitreoretinal Lymphoma | 2017 | 1 |
| 6 | 2014 | 19 | |
| 7 | 2012 | 55 | |
| 8 | 2011 | 48 | |
| 9 | 2008 | 26 | |
| 10 | 2008 | 14 | |
| 11 | 2008 | 35 | |
| 12 | 2006 | 18 | |
| 13 | 2004 | 49 | |
| 14 | 2001 | 30 | |
| 15 | 2001 | 22 | |
| 16 | 2001 | 2 | |
| 17 | 1999 | 4 | |
| 18 | 1999 | 17 | |
| 19 | 1998 | 210 | |
| 20 | Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematuritybreakdown → | 1995 | 1296 |
About Jacob Pe’er
Jacob Pe’er is a scholar working on Ophthalmology, Immunology and Allergy and Oncology, having authored 149 papers that have together received 7.7k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (80 papers), Corneal Surgery and Treatments (20 papers), Glaucoma and retinal disorders (17 papers), Cutaneous Melanoma Detection and Management (16 papers), Ocular Surface and Contact Lens (16 papers), Retinal Development and Disorders (13 papers), Cell Adhesion Molecules Research (11 papers) and Ocular Infections and Treatments (10 papers). The work is most often cited by research in Ophthalmology (3.3k citations), Immunology and Allergy (733 citations) and Cancer Research (1.2k citations). Jacob Pe’er has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Robert Folberg, Ahuva Itin, Eli Keshet, Itzhak Hemo, Andrew J. Maniotis, Jonathan Stone, Tamir Alon, Jeffrey M. Trent, Mary J.C. Hendrix and Elisabeth A. Seftor. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Ophthalmology, American Journal of Ophthalmology, Current Eye Research and Ophthalmologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.